Is the panic about beta-blockers in perioperative care justified?

European Heart Journal

Volumn 35, Issue 36, 2014, Pages 2442-2444

  Lüscher, Thomas F ^a   Gersh, Bernard ^a   Landmesser, Ulf ^a   Ruschitzka, Frank ^a  

^a Zürich Heart House ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BLOODLETTING; CLINICAL PRACTICE; HUMAN; PANIC; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCIENTIFIC MISCONDUCT; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED; FORECASTING; PATIENT SAFETY; PEROPERATIVE COMPLICATION; PREOPERATIVE CARE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADRENERGIC BETA-ANTAGONISTS; CARDIOVASCULAR DISEASES; FORECASTING; HUMANS; INTRAOPERATIVE COMPLICATIONS; PATIENT SAFETY; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907355595     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu056     Document Type: Review

References (19)

1. Husten L. Medicine or Mass Murder? Guideline Based on Discredited Research May Have Caused 800,000 Deaths in Europe over Last 5 Years. http://www.forbes. com/sites/larryhusten/2014/01/15/medicine-or-mass-murder-guidelinebased-on-discredited-research-may-have-caused-800000-deaths-in-europeover-the-last-5-years/(5 February 2014).
2. Retraction of Cardiopulse article, 'Research failure can result in lost lives' by Graham Cole. Eur Heart J 2014;35:820.
3. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H. The effect of bisoprolol on perioperative mortality and myocardial infarction in high risk patients undergoing vascular surgery. N Engl J Med 1999;341:1789-1794.
4. Lüscher TF. Good scientific publishing. Eur Heart J 2012;33:557-561.
5. Lüscher TF. The codex of science. honesty, precision, and truth-And its violations. Eur Heart J 2013;34:1018-1023.
6. Lüscher TF. The bumpy road to evidence: why many research findings are lost in translation. Eur Heart J 2013;34:3329-3335.
7. Popper KR. Conjectures and Refutations. The Growth of Scientific Knowledge. London: Routledge and Kegan Paul; 1963.
8. Ernst E. Heilen ohne Pillen. München: Hanser Verlag; 2011.
9. HarveyW. De motu cordis. 1628.
10. Echt DS, LiebsonPR,Mitchell LB, PetersRW,Obias-Manno D, BarkerAH,Arensberg D, BakerA, FriedmanL, GreeneHL,HutherML, RichardsonDW; theCASTInvestigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl JMed 1991;324:781-788.
11. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL, for the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991;325:1468-1475.
12. POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371;1839-1847.
13. Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery; European Society of Cardiology (ESC), Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Iung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R, Van den Berghe G, Vermassen F. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009;30;2769-2812.
14. Erasmus MC Follow-up Investigation Committee. Report on the 2012 Follow-up Investigation of Possible Breaches of Academic Integrity. 30 September 2012. www. erasmus.nl
15. Feringa HH, Elhendy A, Bax JJ, Boersma E, de Jonge R, Schouten O, Karagiannis SE, Schinkel AF, Lindemans J, Poldermans D. Baseline plasma N-terminal pro-B-type natriuretic peptide is associated with the extent of stress-induced myocardial ischemia during dobutamine stress echocardiography. Coron Artery Dis 2013;24:725.
16. Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP. Meta-Analysis of secure randomised controlled trials of b-blockade to prevent perioperative death in non-cardiac surgery. Heart 2013; doi:10.1136/heartjnl-2013-304262
17. www.escardio.org/guidelines
18. London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013;16:1704-1713.
19. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A; Carvedilol Or Metoprolol European Trial Investigators: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the CarvedilolOrMetoprolol European Trial(COMET): randomised controlled trial. Lancet 2003;362:7-13.